CME Corp. Announces Executive Leadership Transitions
Leadership changes position company for continued national growth and expansion across healthcare continuum
These leadership transitions reflect our commitment to building on CME’s strong foundation and accelerating our growth.”
WARWICK, RI, UNITED STATES, April 1, 2026 /EINPresswire.com/ -- CME Corp. the nation’s premier specialty distributor of healthcare, laboratory, and imaging equipment, today announced strategic executive leadership transitions structured to support the company's continued growth and long-term vision.— Normand Chevrette, Executive Chairman of the Board
Normand Chevrette, CME Corp.'s current Chief Executive Officer, has been appointed Executive Chairman of the Board. In this capacity, Chevrette will focus on corporate governance, stewardship of the company's employee stock ownership plan (ESOP), and long-term strategic initiatives.
KC Meleski, who currently serves as President, will assume the additional role of Chief Executive Officer. As President and CEO, Meleski will lead CME Corp.'s strategic direction, operational execution, and continued expansion into new and emerging areas of healthcare.
Meleski began his career with CME as an Account Manager for the Greater Boston Area in 2001 moving to National Sales Manager, Vice President of Sales, and on to President in 2024. With every role, KC has directly contributed to the growth of CME’s national footprint and reputation in the healthcare industry as a trusted partner. Under KC’s direction, CME has built on its strong foundation by optimizing organizational alignment, strengthening execution, and positioning the company for sustained growth across the healthcare continuum. His commitment to excellence extends beyond CME; since 2018, he has been an active member of the Healthcare Industry Distributors Association (HIDA), serving on the Acute Care Advisory Council and the Board of Directors.
“These leadership transitions reflect our commitment to building on CME’s strong foundation and accelerating our growth,” said Chevrette. “KC is a proven leader with an unwavering dedication to our people, our customers, and the success of our ESOP. He brings the energy, discipline, and vision needed to lead CME into its next chapter.”
“I’m honored to take on the additional role of CEO and continue building on the strong momentum we’ve created,” said KC Meleski. “We remain focused on expanding into new and specialized areas of healthcare while continuing to support the hospitals and IDNs we've built trusted relationships with over the years. Our priority is delivering value, service excellence, and innovative solutions to our customers and vendor partners."
The transitions come at a time of continued growth for CME Corp., as the company expands its reach across the healthcare continuum and strengthens its capabilities to meet evolving customer needs.
About CME Corp.
CME Corp.is the nation's premier specialty distributor of healthcare, laboratory, and imaging equipment. In addition to deep equipment expertise, CME offers a comprehensive suite of services, including CAD-based layout & design, warehousing, direct-to-site delivery, installation, and biomedical and technical services. With over 2 million products sourced from more than 2,000 manufacturers and 25 locations nationwide, CME provides a single-source solution tailored to the needs of healthcare facilities and laboratories. Our mission is to help customers nationwide reduce the total cost of the equipment they purchase and make their equipment specification, installation, and maintenance processes more efficient.
Kristen Sisson, Chief Marketing and Strategy Officer
CME Corp
+1 401-921-8969
email us here
Visit us on social media:
LinkedIn
Facebook
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.